Ultimately, choosing between tirzepatide and semaglutide depends on individual weight loss goals, medical history, tolerance for side effects, and access to care ideally guided by a licensed healthcare provider
There has been significant research in recent years focused on the other potential benefits of GLP-1 analogues, many of which could be due to the impact they have on body mass index (BMI) and obesity
For example, Ipamorelin appears to work by potentially binding to the GHS-R1a receptor, also known as the growth hormone secretagogue receptor type 1a, which is found in the pituitary gland and the hypothalamus
References Buckley ST, Bkdal TA, Vegge A, et al
Safety Considerations and Who Should Start Lower vs
Well-studied peptides like GLP-1 agonists have robust safety profiles from large clinical trials